Philip Macarthy

482 total citations
25 papers, 353 citations indexed

About

Philip Macarthy is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Philip Macarthy has authored 25 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in Philip Macarthy's work include Hepatitis Viruses Studies and Epidemiology (10 papers), Hepatitis B Virus Studies (10 papers) and Viral gastroenteritis research and epidemiology (4 papers). Philip Macarthy is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (10 papers), Hepatitis B Virus Studies (10 papers) and Viral gastroenteritis research and epidemiology (4 papers). Philip Macarthy collaborates with scholars based in United States, United Kingdom and Spain. Philip Macarthy's co-authors include Maria H. Sjögren, Joseph J. Knapka, Harry G. Preuss, Leonard N. Binn, C. H. Hoke, Ann D. King, Sharda G. Sabnis, Llewellyn J. Legters, E. D'Hondt and Joe P. Bryan and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Vaccine.

In The Last Decade

Philip Macarthy

25 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Macarthy United States 13 143 134 103 74 60 25 353
C K Nain India 12 241 1.7× 270 2.0× 83 0.8× 13 0.2× 26 0.4× 37 613
Rosario Casillas Spain 11 337 2.4× 225 1.7× 64 0.6× 152 2.1× 94 1.6× 27 761
Matthew C. Johns United States 9 214 1.5× 131 1.0× 90 0.9× 72 1.0× 19 0.3× 13 447
Yogesh Joshi India 12 254 1.8× 364 2.7× 93 0.9× 35 0.5× 13 0.2× 42 647
C. K. Johnson United States 9 105 0.7× 19 0.1× 66 0.6× 52 0.7× 32 0.5× 12 389
Saqib Walayat United States 10 193 1.3× 163 1.2× 45 0.4× 13 0.2× 18 0.3× 32 465
F Pirali Italy 10 142 1.0× 54 0.4× 29 0.3× 15 0.2× 24 0.4× 26 386
Yii Ean Teh Singapore 7 86 0.6× 66 0.5× 155 1.5× 31 0.4× 18 0.3× 10 417
Ger Bongaerts Netherlands 11 67 0.5× 18 0.1× 96 0.9× 29 0.4× 50 0.8× 28 414
P. O. Abiodun Nigeria 13 77 0.5× 43 0.3× 90 0.9× 64 0.9× 33 0.6× 34 412

Countries citing papers authored by Philip Macarthy

Since Specialization
Citations

This map shows the geographic impact of Philip Macarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Macarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Macarthy more than expected).

Fields of papers citing papers by Philip Macarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Macarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Macarthy. The network helps show where Philip Macarthy may publish in the future.

Co-authorship network of co-authors of Philip Macarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Macarthy. A scholar is included among the top collaborators of Philip Macarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Macarthy. Philip Macarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gaede, Luise, et al.. (2018). Heart Valve Disease Awareness Survey 2017: what did we achieve since 2015?. Clinical Research in Cardiology. 108(1). 61–67. 13 indexed citations
2.
Preuss, Harry G., et al.. (1998). Sugar-Induced Blood Pressure Elevations Over the Lifespan of Three Substrains of Wistar Rats. Journal of the American College of Nutrition. 17(1). 36–37. 19 indexed citations
3.
Cruess, David F., et al.. (1997). Hepatitis B Virus, Human Immunodeficiency Virus Type-1, and Syphilis among Women Attending Prenatal Clinics in Belize, Central America. American Journal of Tropical Medicine and Hygiene. 56(3). 285–290. 10 indexed citations
4.
Macarthy, Philip, et al.. (1997). Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose. American Journal of Infection Control. 25(3). 215–222. 5 indexed citations
5.
DeFraites, Robert F., Brian H. Feighner, Leonard N. Binn, et al.. (1995). Immunization Of Us Soldiers With A Two-Dose Primary Series Of Inactivated Hepatitis A Vaccine: Early Immune Response, Persistence Of Antibody, And Response To A Third Dose At 1 Year. The Journal of Infectious Diseases. 171(Supplement 1). S61–S69. 8 indexed citations
6.
Macarthy, Philip, et al.. (1995). Murine Immunoglobulin G Subclass Responses Following Immunization with Live Dengue Virus or a Recombinant Dengue Envelope Protein. American Journal of Tropical Medicine and Hygiene. 53(4). 432–437. 32 indexed citations
7.
Hoke, C. H., James E. Egan, Maria H. Sjögren, et al.. (1995). Administration Of Hepatitis A Vaccine To A Military Population By Needle And. The Journal of Infectious Diseases. 171(Supplement 1). S53–S60. 17 indexed citations
8.
Kelley, Patrick W., et al.. (1994). Vaccine-preventable disease susceptibility in a young adult Micronesian population.. PubMed. 25(3). 569–74. 4 indexed citations
9.
Bryan, Joe P., Maria H. Sjögren, Joseph L. Malone, et al.. (1993). Recombinant Immunoblot Assays for Hepatitis C in Human Immunodeficiency Virus Type 1-Infected US Navy Personnel. The Journal of Infectious Diseases. 167(3). 715–719. 5 indexed citations
10.
Gaydos, Joel C., et al.. (1993). Initial report of a hepatitis investigation in rural Belize. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87(3). 259–262. 4 indexed citations
11.
Summers, P L, D R Dubois, Philip Macarthy, et al.. (1993). Solid-phase antibody capture hemadsorption assay for detection of hepatitis A virus immunoglobulin M antibodies. Journal of Clinical Microbiology. 31(5). 1299–1302. 3 indexed citations
12.
Sjögren, Maria H., Robert H. Purcell, Kelly T. McKee, et al.. (1992). Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate. Vaccine. 10. S135–S137. 23 indexed citations
13.
Hoke, C. H., Leonard N. Binn, James E. Egan, et al.. (1992). Hepatitis A in the US Army: epidemiology and vaccine development. Vaccine. 10. S75–S79. 31 indexed citations
14.
Binn, Leonard N., Philip Macarthy, Ruth H. Marchwicki, et al.. (1992). Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine. Vaccine. 10. S102–S105. 15 indexed citations
15.
Knapka, Joseph J., et al.. (1992). High Sucrose Diets Increase Blood Pressure of Both Salt-Sensitive and Salt-Resistant Rats. American Journal of Hypertension. 5(9). 585–591. 25 indexed citations
16.
Preuss, Harry G., Joseph J. Knapka, Philip Macarthy, et al.. (1992). Blood Pressure Responses to Sucrose Ingestion in Four Rat Strains. American Journal of Hypertension. 5(4 Pt 1). 244–250. 31 indexed citations
18.
Newsome, Joseph T., et al.. (1991). Blood Pressure in Unilaterally Nephrectomized Rabbits: A Correlation with Serum Renotropic Activity. ˜The œNephron journals/Nephron journals. 58(3). 339–343. 1 indexed citations
19.
Preuss, Harry G., et al.. (1991). Effects of Canrenone on Rrm-Sucrose Hypertension in Wky. Clinical and Experimental Hypertension Part A Theory and Practice. 13(5). 917–923. 3 indexed citations
20.
Macarthy, Philip, Allan A Johnson, & Curla S. Walters. (1987). Iron Nutritional Status of Selected Elderly Black Persons in Washington, D.C.. Journal of Nutrition for the Elderly. 6(2). 3–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026